Company Filing History:
Years Active: 2021-2023
Title: Michael Carl Irizarry: Innovator in Neurodegenerative Disease Treatment
Introduction
Michael Carl Irizarry is a prominent inventor based in Carmel, IN (US). He has made significant contributions to the field of neurodegenerative diseases through his innovative research and patented inventions. With a total of 3 patents, Irizarry's work focuses on developing effective treatments for cognitive disorders.
Latest Patents
Irizarry's latest patents include groundbreaking methods for treating tau-mediated cognitive or neurodegenerative diseases. One of his notable inventions provides a method of administering an effective amount of an anti-Tau antibody alongside an OGA inhibitor to patients in need of treatment. Another significant patent involves the use of anti-N3pGlu amyloid beta peptide antibodies, aimed at short-term induction treatment for diseases characterized by Aβ deposition in the brain, such as Alzheimer's disease, Down's syndrome, and cerebral amyloid angiopathy. In specific embodiments, patients receive an induction dose of 10 to 60 mg/kg of the anti-N3pGlu Aβ antibody for a duration of six months or less.
Career Highlights
Irizarry's career is marked by his association with Eli Lilly and Company, where he has been instrumental in advancing research in neurodegenerative diseases. His work has not only contributed to the scientific community but has also paved the way for potential therapeutic solutions for patients suffering from these debilitating conditions.
Collaborations
Irizarry has collaborated with esteemed colleagues, including Mansuo Lu Hayashi and Hugh Nuthall, to further enhance the impact of his research. These collaborations have fostered a productive environment for innovation and development in the field.
Conclusion
Michael Carl Irizarry stands out as a key figure in the fight against neurodegenerative diseases, with his innovative patents and collaborative efforts contributing to significant advancements in treatment options. His work continues to inspire and pave the way for future research in this critical area of healthcare.